par Piagnerelli, Michaël 
;Vincent, Jean Louis
Référence Critical care clinics, 28, 3, page (345-62, v)
Publication Publié, 2012-07
;Vincent, Jean Louis Référence Critical care clinics, 28, 3, page (345-62, v)
Publication Publié, 2012-07
Article révisé par les pairs
| Résumé : | Anemia is common in critically ill patients, but treatment with red blood cell transfusions can have unwanted effects. Limiting the occurrence and severity of anemia by using erythropoietic agents (iron and/or recombinant erythropoietin), therefore, remains an attractive option during the intensive care unit stay but also after hospital discharge. Moreover, these agents may have additional beneficial properties. In this article the authors review the rationale for the administration of iron and/or erythropoietin in critically ill patients. |
